Schedule Update - effective 1 March 2010 (text extract)

This is the text extract for Schedule Update - effective 1 March 2010, browse documents here.

Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 March 2010 Cumulative for January, February and March 2010 Section H cumulative for December 2009, January, February and March 2010

Contents

Summary of PHARMAC decisions effective 1 March 2010 ............................. 3 New multivitamin subsidised ........................................................................ 4 Ursodeoxycholic acid – widened access ......................................................... 4 Close Control – diclofenac sodium and prazosin hydrochloride .................... 4 Crotamiton cream – now fully subsidised...................................................... 5 Stelazine tablets now registered ................................................................... 5 Nicotine replacement therapy and access exemption .................................... 5 Cost Brand Source claimed prescriptions....................................................... 6 Arrow-metformin – delay in delisting ............................................................ 6 Tender News .................................................................................................. 7 Looking Forward ........................................................................................... 7 Sole Subsidised Supply products cumulative to March 2010......................... 8 New Listings ................................................................................................ 17 Changes to Restrictions ............................................................................... 20 Changes to Subsidy and Manufacturer’s Price............................................. 25 Changes to General Rules............................................................................ 30 Changes to Sole Subsidised Supply ............................................................. 30 Changes to Section E Part I ......................................................................... 30 Delisted Items ............................................................................................. 31 Items to be Delisted .................................................................................... 34 Section H changes to Part II ........................................................................ 38 Section H changes to Part IV ....................................................................... 46 Index ........................................................................................................... 47

Summary of PharmaC decisions

effeCtIve 1 marCh 2010 New listings (pages 17-18) • Vitamins (Vitabdeck) cap (fat soluble vitamins A, D, E, K) – Special Authority – retail pharmacy • Crotamiton (Itch-Soothe) crm 10% - only on a prescription and not in combination • Chlorhexidine gluconate (healthE) handrub 1% with ethanol 70% - subsidy by endorsement – not more than 500 ml per month • Pregnancy tests – hCG urine (Innovacon hCG One Step Pregnancy Test Device) cassette – only on a PSO, up to 200 test available on a PSO • Influenza vaccine (Influvac) inj – Hospital pharmacy [Xpharm] • Megestrol acetate (Apo-Megestrol) tab 160 mg – Retail pharmacy-Specialist Changes to restrictions (pages 20-22) • Ursodeoxycholic acid (Actigall) cap 300 mg – amended Special Authority criteria • Diltiazem hydrochloride (Cardizam CD) cap long-acting 120 mg – amended presentation description • Nicotine (Habitrol and Nicotinell) gum 2 mg and 4 mg (fruit and mint) – maximum per dispensing can not be waived via Access Exemption criteria • Nicotine (Habitrol) lozenge 1 mg and 2 mg – maximum per dispensing can not be waived via Access Exemption criteria • Nicotine (Habitrol) patch 7 mg, 14 mg and 21 mg – maximum per dispensing can not be waived via Access Exemption criteria • Influenza vaccine (Fluvax, Fluarix, Influvac and Vaxigrip) inj – amended access criteria • Trifluoperazine hydrochloride (Stelazine) tab 1 mg, 2 mg and 5 mg – removal of Section 29 criteria Decreased subsidy (page 25) • Paracetamol with codeine (Codalgin) tab paracetamol 500 mg with codeine phosphate 8 mg Increased subsidy (page 25) • Sulphasalazine tab 500 mg (Salazopyrin) and tab EC 500 mg (Salazyprin EN) • Apomorphine hydrochloride (Apomine) inj 10 mg per ml, 2 ml • Lithium carbonate (Priadel) tab long-acting 400 mg • Lorazepam (Ativan) tab 1 mg and 2.5 mg

4 Pharmaceutical Schedule - Update News

New multivitamin subsidised

A new multivitamin supplement will be subsidised from 1 March 2010. Vitabdeck is a fat soluble vitamin capsule containing vitamins A, D, E and K. It will be subsidised under Special Authority criteria for patients with cystic fibrosis with pancreatic insufficiency and for children with liver disease or short gut syndrome.

Ursodeoxycholic acid – widened access

Access will be widened for ursodeoxycholic acid 300 mg capsules from 1 March 2010. The Special Authority criteria will be amended to include cholestasis of pregnancy.

Close Control – diclofenac sodium and prazosin hydrochloride

There are currently four formulations where pharmacists can initiate Close Control monthly dispensing due to out-of-stock situations – diclofenac sodium tablets longacting 75 mg and 100 mg, and prazosin hydrochloride tablets 1 mg and 2 mg. Diclofenac sodium tablets long-acting 75 mg and 100 mg have been on Close Control since 11 September 2009. Alternate brands have been listed but stock levels remain tight. Please continue to dispense prescriptions for these formulations monthly and annotate the prescription Close Control. Prazosin hydrochloride tablets 1 mg and 2 mg have only recently gone onto Close Control dispensing. PHARMAC is continuing to monitor the levels of these products in the distribution chain. We will notify pharmacy via fax of the end date of Close Control for any of these products.

Pharmaceutical Schedule - Update News

Crotamiton cream – now fully subsidised

From 1 March 2010 the Itch-Soothe brand of crotamiton cream 10% will be listed fully subsidised. This new brand is fully subsidised while the other brand listed, Eurax, incurs a manufacturers’ surcharge. The Eurax brand will be reference priced from 1 May 2010 and will be delisted on 1 August 2010.

Stelazine tablets now registered

Stelazine (trifluoperazine hydrochloride) tab 1 mg, 2 mg and 5 mg has been approved by the Minister of Health for distribution within New Zealand. This brand of trifluoperazine hydrochloride has been supplied under Section 29 of the Medicines Act since early 2007; however, this restriction no longer applies.

Nicotine replacement therapy and access exemption

As you are aware, Nicotine Replacement Therapy (NRT) became funded on the presentation of either a prescription or a Quit Card from 1 September 2009. This enabled practitioners, but not Quit Card Providers, to write a prescription for subsidised NRT as an alternative to the Quit Cards. Quit Card providers can continue to provide subsidised NRT via Quit Cards. There appears to be some confusion around the stat or all-at-once dispensing rules for NRT. Eight weeks stat supply of NRT cannot be supplied under Access Exemption Criteria. We are amending the restrictions for NRT to clarify that the maximum numbers per dispensing can not be waived via the Access Exemption Criteria.

6 Pharmaceutical Schedule - Update News

Cost Brand Source claimed prescriptions

The way Cost Brand Source of Supply (CBS) medicines are claimed on prescriptions will change from 1 March 2010. Pharmacists can either remain with their current process of annotating the prescription with the cost, brand and source of supply or choose to switch to the new method of claiming with this information. Pharmacists will be able to attach a copy of the purchase invoice to the prescription instead of annotating the prescription with the cost, brand and source of supply. The electronic claiming system remains unchanged. Where CBS is indicated against a medicine in the Pharmaceutical Schedule, or if the item is an Exceptional Circumstances

medicine not listed in the Pharmaceutical Schedule, the amount claimed should match the invoice price (exclusive of GST). Please be aware that details of the purchase may be subject to audit by Audit and Compliance. All purchase invoices must be kept.

Arrow-Metformin - delay in delisting

Following an agreement between Arrow Pharmaceuticals and Apotex New Zealand, the delisting of the Arrow-Metformin brand of metformin 500 mg and 850 mg immediaterelease tablets will be delayed by one month from 1 April 2010 to 1 May 2010. Sole Supply Status will apply to Apotex's brand of metformin 500 mg and 850 mg immediate-release tablets from 1 May 2010.

tender News

Sole Subsidised Supply changes – effective 1 April 2010

Chemical Name Amoxycillin clavulanate Amoxycillin clavulanate Cyproterone acetate with ethinyloestradiol Etidronate disodium Mometasone furoate Mometasone furoate Tropisetron Presentation; Pack size Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml; 100 ml Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml; 100 ml Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs; 84 tab Tab 200 mg; 100 tab Crm 0.1%; 15 g OP & 45 g OP Oint 0.1%; 15 g OP & 45 g OP Cap 5 mg; 5 cap Sole Subsidised Supply brand (and supplier) Curam (Sandoz) Curam (Sandoz) Ginet 84 (Rex) Arrow-Etidronate (Arrow) m-Mometasone (Multichem) m-Mometasone (Multichem) Navoban (Novartis)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Possible decisions for implementation 1 april 2010 • Alendronate for osteoporosis – amended Special Authority criteria • Ambrisentan (Volibris) tab 5 mg and 10 mg – new listing – Special Authority – Hospital pharmacy [HP1] • Bisacodyl (Dulcolax) suppos 5 mg – subsidy increase to match price • Bisacodyl (Dulcolax) suppos 10 mg – new listing • Letrozole (Femara) tab 2.5 mg – subsidy decrease • Prednisolone acetate eye drops 0.12% (Pred Mild) and 1% (Pred Forte) – price decrease to match subsidy • Topiramate (Arrow-Topiramate) tab 25 mg, 50 mg, 100 mg and 200 mg – new listing Decision for implementation 1 July 2010 • Metoprolol succinate (AFT-Metoprolol CR and Betaloc CR) tab long-acting 23.75 mg, 47.5 mg, 95 mg and 190 mg – subsidy decrease

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Acarbose Acetazolamide Allopurinol Alprazolam Amantadine hydrochloride Amlodipine Amoxycillin

Presentation

Tab 50 mg & 100 mg Tab 250 mg Tab 100 mg & 300 mg Tab 250 µg, 500 µg & 1 mg Cap 100 mg Tab 5 mg & 10 mg Drops 125 mg per 1.25 ml Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg

Brand Name Expiry Date*

Glucobay Diamox Apo-Allopurinol Arrow-Alprazolam Symmetrel Apo-Amlodipine Ospamox Paediatric Drops Ibiamox Apo-Amoxi Synermox AFT Ethics Aspirin Ethics Aspirin EC Pacific Atenolol AstraZeneca Arrow-Azithromycin Pacifen Sandoz Beta Scalp Fibalip Bicalox Lax-Tabs AFT Marcain Isobaric Marcain Heavy healthE API Miacalcic Calsource Calcium Folinate Ebewe Apo-Captopril Ranbaxy-Cefaclor Ranbaxy-Cefaclor Hospira Zinacef 2012 2011 2011 2010 2011 2011 2011 2010 2011 2011 2010 2012 2012 2012 2012 2011 2012 2011 2011 2010 2011 2010 2012 2011 2011 2011 2010 2010 2011 2011

Amoxycillin clavulanate Aqueous cream Aspirin Atenolol Atropine sulphate Azithromycin Baclofen Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezafibrate Bicalutamide Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine Calcitonin Calcium Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Cefuroxime sodium

Tab amoxycillin 500 mg with potassium clavulanate 125 mg Crm 500 g Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Inj 600 µg, 1 ml Tab 500 mg Tab 10 mg Inj 1 mega u Scalp app 0.1% Tab 200 mg Tab 50 mg Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Crm, aqueous, BP Lotn, BP Inj 100 iu per ml, 1 ml Tab eff 1 g Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 750 mg & 1.5 g

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Cephalexin monohydrate Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate Ciclopiroxolamine Ciprofloxacin Citalopram Clarithromycin Clobetasol propionate

Presentation

Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Crm BP Tab 10 mg Oral liq 1 mg per ml Eye oint 1% Soln 4% Nail soln 8% Tab 250 mg, 500 mg & 750 mg Tab 20 mg Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Oint 0.05% Scalp app 0.05% Tab 500 µg & 2 mg TDDS 2.5 mg, 100 µg per day TDDS 5 mg, 200 µg per day TDDS 7.5 mg, 300 µg per day Inj 150 µg per ml, 1 ml Tab 25 µg Tab 150 µg Crm 1% Vaginal crm 1% with applicator(s) Vaginal crm 2% with applicators(s) Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg Tab 50 mg & 100 mg Inj 500 mg Nasal spray 10 µg per dose Tab 5 mg Inj 50%, 10 ml

Brand Name Expiry Date*

Cefalexin Sandoz Cefalexin Sandoz PSM Zetop Cetirizine-AFT Chlorsig Orion Batrafen Rex Medical Arrow-Citalopram Klamycin Klacid Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Catapres Dixarit Catapres Clomazol Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin Siterone Mayne Desmopressin-PH&T PSM Biomed 2012 2010 2011 2012 2011 2012 2011 2011 2010 2012

Clonazepam Clonidine

2011 2012

Clonidine hydrochloride

2012

Clotrimazole

2011 2010 2010 2010 2010 2010 2010 2012 2010 2012 2010 2011 2010 2011

Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide Cyproterone acetate Desferrioxamine mesylate Desmopressin Dexamphetamine sulphate Dextrose

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Dextrose with electrolytes

Presentation

Oral soln with electrolytes

Brand Name Expiry Date*

Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit Diclohexal Voltaren Ophtha Voltaren Voltaren Dilzem Cardizem CD Pytazen SR Apo-Doxazosin AFT Clexane Comtan E-Mycin E-Mycin E-Mycin NZ Medical and Scientific Brevinor 21 Brevinor 1/21 Brevinor 1/28 Felo 5 ER Felo 10 ER Ferodan Fintral AFT AFT Flucloxin Pacific Fludara Fludara Oral Ultraproct Ultraproct 2012 2010 2011 2012 2011 2011 2011 2010 2010

Diclofenac sodium

Tab EC 25 mg & 50 mg Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab 30 mg & 60 mg Cap long-acting 120 mg, 180 mg & 240 mg Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Tab 400 mg Grans for oral liq 200 mg per 5 ml Grans for oral liq 400 mg per 5 ml Tab 10 µg Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Tab long-acting 5 mg Tab long-acting 10 mg Oral liq 150 mg per 5 ml Tab 5 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Inj 250 mg, 500 mg & 1 g Cap 50 mg, 150 mg & 200 mg Inj 50 mg Tab 10 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg

2012 2011

Diltiazem hydrochloride

2011

Dipyridamole Doxazosin mesylate Emulsifying ointment Enoxaparin sodium (low molecular weight heparin) Entacapone Erythromycin ethyl succinate

2011 2010 2011 2012 2012 2012 2011 2012 2010

Ethinyloestradiol Ethinyloestradiol with norethisterone

Felodipine Ferrous sulphate Finasteride Flucloxacillin sodium

Fluconazole Fludarabine phosphate Fluocortolone caproate with fluocortolone pivalate and cinchocaine

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Fluoromethalone Fluoxetine hydrochloride Fluticasone propionate Furosemide Fusidic acid Gabapentin Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

Presentation

Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Metered aqueous nasal spray, 50 µg per dose Tab 40 mg Crm 2% Oint 2% Cap 100 mg, 300 mg & 400 mg Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Tab 600 µg Oral pump spray 400 µg per dose TDDS 5 mg & 10 mg

Brand Name Expiry Date*

FML Fluox Fluox Flixonase Hayfever & Allergy Diurin 40 Foban Foban Nupentin Pfizer Apo-Gliclazide Minidiab Lycinate Nitrolingual Pumpspray Nitroderm TTS Serenace Serenace Douglas ABM PSM Colifoam Locoid DP Lotn HC Plaquenil Methopt Buscopan Gastrosoothe Ethics Ibuprofen Fenpaed Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Oratane Sporanox Sebizole Duphalac 2012 2010 31/1/13 2012 2010 31/7/12 2012 2011 2011 2011

Haloperidol Hydrocortisone

Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Tab 5 mg & 20 mg Powder Crm 1% Rectal foam 10%, CFC-free (14 applications) Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Tab 200 mg Eye drops 0.5% Inj 20 mg, 1 ml Tab 20 mg Tab 200 mg Oral liq 100 mg per 5 ml Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Inj 50 mg per ml, 2 ml Cap 10 mg & 20 mg Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml

2010 2012 2011 2012 2010 2011 2012 2011 2011 2012 2010 2010

Hydrocortisone acetate Hydrocortisone butyrate Hydrocortisone with wool fat and mineral oil Hydroxychloroquine sulphate Hypromellose Hysocine N-butylbromide Ibuprofen Ipratropium bromide

Iron polymaltose Isotretinoin Itraconazole Ketoconazole Lactulose

2011 2012 2010 2011 2010

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Latanoprost Levobunolol Lignocaine hydrochloride

Presentation

Eye drops 50 µg per ml Eye drops 0.25% & 0.5% Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Hysite Betagan Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Derbac M A-Lices Foremount Child’s Silicone Mask De-Worm Colofac Provera Pentasa Biodone Biodone Forte Biodone Extra Forte Methatabs Methoblastin Methotrexate Ebewe Methotrexate Ebewe Prodopa Medrol Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Multichem 2012 2010 2010 2012 2010 2010

Lignocaine with prilocaine

2010

Lisinopril Loperamide hydrochloride Loratadine

Malathion Mask for Spacer Device Mebendazole Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Methadone hydrochloride

Liq 0.5% Shampoo 1% Device Tab 100 mg Tab 135 mg Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab 5 mg Tab 2.5 mg & 10 mg Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 125 mg, 250 mg & 500 mg Tab 4 mg & 100 mg Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 2 ml Inj 500 mg Inj 1 g Inj 5 mg per ml, 2 ml Crm 2%

2010 2011 30/9/11 2011 2011 2010 2012 2012 2010 2012 2011 2011 2012 2011 2011 2012

Methotrexate

Methyldopa Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate

Metoclopramide hydrochloride Miconazole nitrate

2011 2011

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Morphine hydrochloride

Presentation

Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab immediate release 10 mg & 20 mg Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Tab 40 mg & 80 mg Tab 50 mg Tab 250 mg Tab 500 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 200 mg

Brand Name Expiry Date*

RA-Morph RA-Morph RA-Morph RA-Morph Sevredol Mayne Mayne Apo-Nadolol ReVia Noflam 250 Noflam 500 Sonaflam AstraZeneca Viramune Suspension Viramune Habitrol Habitrol Habitrol Habitrol Noriday 28 Primolut N Norpress Nilstat Nilstat Nilstat Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Zofran Zofran Zydis Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol 2012

Morphine sulphate

2012 2011 2010 2010 2012 2010 2010 2012

Nadolol Naltrexone hydrochloride Naproxen Naproxen sodium Neostigmine Nevirapine

Nicotine

Patch 7 mg, 14 mg & 21 mg Lozenge 1 mg & 2 mg Gum 2 mg & 4 mg (Fruit) Gum 2 mg & 4 mg (Mint) Tab 350 µg Tab 5 mg Tab 10 mg & 25 mg Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u Cap 10 mg, 20 mg & 40 mg Inj 40 mg

2010

Norethisterone Nortriptyline hydrochloride Nystatin

2012 2011 2011 2011 2010 2011

Omeprazole

Ondansetron Oxybutynin Oxycodone hydrochloride Oxytocin

Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml & 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml

2010 2010 2010 2012

Pamidronate disodium

2011

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Pantoprazole

Presentation

Inj 40 mg Tab 20 mg & 40 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Eye oint with soft white paraffin Tab 20 mg Low range and Normal range

Brand Name Expiry Date*

Pantocid IV Dr Reddy’s Pantoprazole Pharmacare Paracare Junior Paracare Double Strength Lacri-Lube Loxamine Breath-Alert Pegasys Pegasys Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Permax AFT AFT Cilicaine VK Prefrin Pizaccord Coloxyl Vistil Vistil Forte Span-K Apo-Prazo Apo-Prednisone Redipred Cilicaine Allersoothe Accupril Accuretic 10 Accuretic 20 Q 300 2012 2010

Paracetamol

2011

Paraffin liquid with soft white paraffin Paroxetine hydrochloride Peak Flow Meter

2010 2010 30/9/11 31/12/12

Pegylated interferon alpha-2A Inj 135 µg prefilled syringe Inj 180 µg prefilled syringe Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112 Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168 Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112 Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168 Pergolide Phenoxymethylpenicillin (Penicillin V) Phenylephrine hydrochloride Pioglitazone Poloxamer Polyvinyl alcohol Potassium chloride Prazosin hydrochloride Prednisone Prednisone sodium phosphate Procaine penicillin Promethazine Quinapril Quinapril with hydroclorothiazide Tab 0.25 mg & 1 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg & 500 mg Eye drops 0.12% Tab 15 mg, 30 mg & 45 mg Oral drops 10% Eye drops 1.4% Eye drops 3% Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg, 2.5 mg, 5 mg & 20 mg Oral liq 5 mg per ml Inj 1.5 mega u Tab 10 mg & 25 mg Tab 5 mg, 10 mg & 20 mg Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 300 mg

2011 2010

2010 2012 2011 2011 2012 2010 2011 2012 2011 2011 2011 2011

Quinine sulphate

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Ranitidine hydrochloride Rifabutin Ropinirole hydrochloride Roxithromycin Salbutamol

Presentation

Oral liq 150 mg per 10 ml Cap 150 mg Tab 0.25 mg, 1 mg, 2 mg and 5 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml, 2.5 ml Nebuliser soln, 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratopium bromide 0.5 mg per vial, 2.5 ml Tab 5 mg Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg Grans eff 4 g sachets Nasal spray, 4% Tab 80 mg & 160 mg 230 ml Liq Soln 2.3% Tab 10 mg Tab 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 µg Inj 1 mg per ml, 1 ml Tab 10 mg Eye drops 0.25% & 0.5% Crm 0.02% Oint 0.02% Inj 40 mg per ml, 1 ml 0.1% in Dental Paste USP Tab 300 mg Cap 300 mg Inj 50 mg per ml, 10 ml Oint BP Cap 220 mg

Brand Name Expiry Date*

Peptisoothe Mycobutin Ropin ArrowRoxithromycin Asthalin Asthalin Salapin Duolin 2010 2010 2010 2012 2012 2010 2012

Salbutamol with ipratropium bromide Selegiline hydrochloride Simvastatin

Apo-Selegiline Arrow-Simva 10 mg Arrow-Simva 20 mg Arrow-Simva 40 mg Arrow-Simva 80 mg Ural Rex Mylan Space Chamber Midwest Pinetarsol Normison Apo-Terazosin Apo-Terbinafine Depo-Testosterone Synacthen Synacthen Depot Apo-Timol Apo-Timop Aristocort Aristocort Kenacort-A40 Oracort TMP Actigall Pacific PSM Zincaps

2012 2011

Sodium citro-tartrate Sodium cromoglycate Sotalol Spacer Device Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Terazosin hydrochloride Terbinafine Testosterone cypionate Tetracosactrin Timolol maleate Triamcinolone acetonide

2010 2012 2012 30/9/11 2010 2011 2011 2010 2011 2011 2011 2012 2011 2011

Trimethoprim Ursodeoxycholic acid Vancomycin hydrochloride Zinc and castor oil Zinc sulphate

2011 2011 2011 2011 2011

Sole Subsidised Supply Products – cumulative to March 2010

Generic Name

Zopiclone March changes in bold

Presentation

Tab 7.5 mg

Brand Name Expiry Date*

Apo-Zopiclone 2011

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 March 2010

37 VITAMINS ❋ Cap (fat soluble vitamins A, D, E, K) – Special Authority see SA1002 – Retail pharmacy .................. 23.40 60 ✔ Vitabdeck ➽ SA1002 Special Authority for Subsidy Initial Application from any relevant practitioner. Approvals valid without further renewal unless notified for applications meeting the following criteria: Either: 1. Patient has cystic fibrosis with pancreatic insufficiency; or 2. Patient is an infant or child with liver disease or short gut syndrome. CROTAMITON a) Only on a prescription b) Not in combination Crm 10% ................................................................................... 3.79

20 g OP

✔ Itch-Soothe

CHLORHEXIDINE GLUCONATE - Subsidy by endorsement a) No more than 500 ml per month b) Only if prescribed for a dialysis patient and the prescription is endorsed accordingly ❋ Handrub 1% with ethanol 70% ................................................... 4.60 500 ml ✔ healthE PREGNANCY TESTS - HCG URINE – Only on a PSO Cassette – Up to 200 test available on a PSO ........................... 22.80 40 test OP ✔ Innovacon hCG One Step Pregnancy Test Device

INFLUENZA VACCINE – Hospital pharmacy [Xpharm] A) is available between 1 March and 30 June each year for patients who meet the following criteria, as set by the Ministry of Health: a) all people 65 years of age and over; b) people under 65 years of age with: i) the following cardiovascular disease: 1) ischaemic heart disease, 2) congestive heart disease, 3) rheumatic heart disease, 4) congenital heart disease, or 5) cerebo-vascular disease; ii) the following chronic respiratory disease: 1) asthma, if on a regular preventative therapy, or 2) other chronic respiratory disease with impaired lung function; iii)diabetes; iv) chronic renal disease; v) any cancer, excluding basal and squamous skin cancers if not invasive; vi) the following other conditions: a) autoimmune disease, b) immune suppression, c) HIV, d) transplant recipients, e) neuromuscular and CNS diseases, f) haemoglobinopathies, or g) children on long term aspirin. c) people under 65 years of age who are: continued... Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. ❋ Three months or six months, as applicable, dispensed all-at-once

▲

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 March 2010 (continued)

continued... i) pregnant; or ii) morbidly obese d) children under the age of 5 who are enrolled with an Access Primary Health Organisation The following conditions are excluded from funding: a) asthma not requiring regular preventative therapy, b) hypertension and/or dyslipidaemia without evidence of end-organ disease, B) Doctors are the only Contractors entitled to claim payment from the Funder for the supply of influenza vaccine to patients eligible under the above criteria for subsidised immunisation and they may only do so in respect of the influenza vaccine listed in the Pharmaceutical Schedule. C) Individual DHBs may fund patients over and above the above criteria. The claiming process for these additional patients should be determined between the DHB and Contractor. D) Influenza Vaccine does not fall within the definition Community Pharmaceutical as it is not funded directly from the Pharmaceutical Budget. Pharmacists are unable to claim for the dispensing of influenza vaccine from the Funder. Inj ........................................................................................... 90.00 10 ✔ Influvac 30 ✔ Apo-Megestrol

146

MEGESTROL ACETATE – Retail pharmacy-Specialist Tab 160 mg ............................................................................ 57.92

Effective 1 February 2010

31 BLOOD GLUCOSE DIAGNOSTIC TEST METER – Subsidy by endorsement a) Maximum of 1 meter per prescription b) 1) A diagnostic blood glucose test meter is subsidised for patients who begin insulin or sulphonylurea therapy after 1 March 2005 or is prescribed for a pregnant woman with diabetes. 2) Only one meter per patient. No further prescriptions will be subsidised. The prescription must be endorsed accordingly. Meter ........................................................................................ 9.00 1 ✔ On Call Advanced BLOOD GLUCOSE DIAGNOSTIC TEST STRIP The number of test strips available on a prescription is restricted to 50 unless: 1) Prescribed with insulin or a sulphonylurea but are on a different prescription and the prescription is endorsed accordingly; or 2) Prescribed on the same prescription as insulin or a sulphonylurea in which case the prescription is deemed to be endorsed; or 3) Prescribed for a pregnant woman with diabetes and endorsed accordingly. Blood glucose test strips × 50 and lancets × 5 ...................... 19.10 1 OP ✔ On Call Advanced SUMATRIPTAN Tab 50 mg ............................................................................. 38.83 Tab 100 mg ........................................................................... 77.66 RISPERIDONE Tab 0.5 mg .............................................................................. 3.51 Tab 1 mg ................................................................................. 6.00 Tab 2 mg ............................................................................... 11.00 100 100 60 60 60 ✔ Arrow-Sumatriptan ✔ Arrow-Sumatriptan ✔ Apo-Risperidone ✔ Apo-Risperidone ✔ Dr Reddy’s Risperidone ✔ Apo-Risperidone ✔ Dr Reddy’s Risperidone continued... Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

S29

119

125

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 February 2010 (continued)

continued... Tab 3 mg ............................................................................... 15.00 Tab 4 mg ............................................................................... 20.00 Oral liq 1 mg per ml ................................................................ 18.35 134 60 60 30 ml ✔ Apo-Risperidone ✔ Dr Reddy’s Risperidone ✔ Apo-Risperidone ✔ Dr Reddy’s Risperidone ✔ Apo-Risperidone

METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE – Special Authority see SA0924 – Retail pharmacy Only on a controlled drug form Cap modified-release 10 mg ................................................... 19.50 30 ✔ Ritalin LA DASATINIB – Special Authority see SA0976 Tab 100 mg ...................................................................... 6,214.20 LETROZOLE Tab 2.5 mg ............................................................................ 26.55 PROMETHAZINE HYDROCHLORIDE ❋‡ Oral liq 5 mg per 5 ml ............................................................. 3.10 FLUTICASONE PROPIONATE Metered aqueous nasal spray, 50 µg per dose ......................... 13.34 30 30 100 ml ✔ Sprycel ✔ Letara ✔ Promethazine Winthrop Elixir

144 146 151 155

120 dose OP ✔ Flixonase Hayfever & Allergy

Effective 1 January 2010

26 52 MESALAZINE Tab EC 500 mg ...................................................................... 49.50 PINDOLOL ❋ Tab 5 mg ................................................................................. 5.40 ❋ Tab 10 mg ............................................................................... 9.19 ❋ Tab 15 mg ............................................................................. 13.80 SILVER SULPHADIAZINE Crm 1% .................................................................................. 12.30 a) Up to 250 g available on a PSO b) Not in combination 100 100 100 100 50 g OP ✔ Asamax ✔ Apo-Pindolol ✔ Apo-Pindolol ✔ Apo-Pindolol ✔ Flamazine

SOLIFENACIN SUCCINATE – Special Authority see SA0998 – Retail pharmacy Tab 5 mg ................................................................................ 56.50 30 ✔ Vesicare Tab 10 mg .............................................................................. 56.50 30 ✔ Vesicare ➽ SA0998 Special Authority for Subsidy Initial application from any relevant practitioner. Applications valid without further renewal unless notified for applications where the patient has overactive bladder and a documented intolerance of oxybutynin. FLUCLOXACILLIN SODIUM Cap 250 mg – Up to 30 cap available on a PSO ....................... 32.00 Cap 500 mg ......................................................................... 110.00 PARACETAMOL WITH CODEINE ❋ Tab paracetamol 500 mg with codeine phosphate 8 mg ............. 2.45 250 500 100 ✔ AFT ✔ AFT ✔ ParaCode

112

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 March 2010

33 URSODEOXYCHOLIC ACID – Special Authority see SA1003 0914 – Retail pharmacy Cap 300 mg .......................................................................... 179.00 100 ✔ Actigall ➽ SA1003 0914 Special Authority for Subsidy Initial application from any relevant practitioner. Approvals valid for 6 months for applications meeting the following criteria: Either 1. Patient diagnosed with cholestasis of pregnancy; or 2. Both: 1 2.1 Primary biliary cirrhosis confirmed by antimitochondrial antibody titre (AMA) > 1:80, and raised cholestatic liver enzymes with or without raised serum IgM or, if AMA is negative, by liver biopsy; and 2 2.2 Patient not requiring a liver transplant (bilirubin > 170umol/l; decompensated cirrhosis). Note: Liver biopsy is not usually required for diagnosis but is helpful to stage the disease. Renewal from any relevant practitioner. Approvals valid for 2 years where the treatment remains appropriate and the patient is benefiting from treatment. Note: Ursodeoxycholic acid Actigall is not an appropriate therapy for patients requiring a liver transplant (bilirubin > 170 micromol/l; decompensated cirrhosis). These patients should be referred to an appropriate transplant centre. Treatment failure – doubling of serum bilirubin levels, absence of a significant decrease in ALP or ALT and AST, development of varices, ascites or encephalopathy, marked worsening of pruritus or fatigue, histological progression by two stages, or to cirrhosis, need for transplantation. 53 55 DILTIAZEM HYDROCHLORIDE ❋ Cap long-acting 120 mg (once per day) ..................................... 4.34 30 ✔ Cardizem CD

NICOTINE a) Maximum of 768 piece per prescription b) Maximum of 384 piece per dispensing c) For the avoidance of doubt Nicotine will not be funded Close Control in amounts less than 4 weeks. d) The maximum of 384 piece per dispensing cannot be waived via Access Exemption Criteria. Gum 2 mg (Fruit) ..................................................................... 14.97 96 OP ✔ Habitrol 23.41 ✔ Nicotinell Gum 2 mg (Mint)..................................................................... 14.97 96 OP ✔ Habitrol 23.41 ✔ Nicotinell Gum 4 mg (Fruit) ..................................................................... 20.02 96 OP ✔ Habitrol 23.41 ✔ Nicotinell Gum 4 mg (Mint)..................................................................... 20.02 96 OP ✔ Habitrol 23.41 ✔ Nicotinell NICOTINE a) Maximum of 432 loz per prescription b) Maximum of 216 loz per dispensing c) For the avoidance of doubt Nicotine will not be funded Close Control in amounts less than 4 weeks. d) The maximum of 216 loz per dispensing cannot be waived via Access Exemption Criteria. Lozenge 1 mg ......................................................................... 11.08 36 OP ✔ Habitrol Lozenge 2 mg ......................................................................... 11.08 36 OP ✔ Habitrol

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 March 2010 (continued)

55 NICOTINE a) Maximum of 56 patch per prescription b) Maximum of 28 patch per dispensing c) For the avoidance of doubt Nicotine will not be funded Close Control in amounts less than 4 weeks. d) The maximum of 28 patch per dispensing cannot be waived via Access Exemption Criteria. Patch 7 mg ............................................................................ 10.53 7 OP ✔ Habitrol Patch 14 mg ........................................................................... 11.63 7 OP ✔ Habitrol Patch 21 mg ........................................................................... 12.32 7 OP ✔ Habitrol INFLUENZA VACCINE – Hospital pharmacy [Xpharm] A) is available between 1 March and 30 June each year for patients who meet the following criteria, as set by the Ministry of Health: a) all people 65 years of age and over; b) people under 65 years of age with: i) the following cardiovascular disease: 1) ischaemic heart disease, 2) congestive heart disease, 3) rheumatic heart disease, 4) congenital heart disease, or 5) cerebo-vascular disease; ii) the following chronic respiratory disease: 1) asthma, if on a regular preventative therapy, or 2) other chronic respiratory disease with impaired lung function; iii)diabetes; iv) chronic renal disease; v) any cancer, excluding basal and squamous skin cancers if not invasive; vi) the following other conditions: a) autoimmune disease, b) immune suppression, c) HIV, d) transplant recipients, e) neuromuscular and CNS diseases, f) haemoglobinopathies, or g) children on long term aspirin. c) people under 65 years of age who are: i) pregnant; or ii) morbidly obese d) children under the age of 5 who are enrolled with an Access Primary Health Organisation The following conditions are excluded from funding: a) asthma not requiring regular preventative therapy, b) hypertension and/or dyslipidaemia without evidence of end-organ disease. c) pregnancy in the absence of another risk factor. B) Doctors are the only Contractors entitled to claim payment from the Funder for the supply of influenza vaccine to patients eligible under the above criteria for subsidised immunisation and they may only do so in respect of the influenza vaccine listed in the Pharmaceutical Schedule. C) Individual DHBs may fund patients over and above the above criteria. The claiming process for these additional patients should be determined between the DHB and Contractor. D) Influenza Vaccine does not fall within the definition Community Pharmaceutical as it is not funded directly from the Pharmaceutical Budget. Pharmacists are unable to claim for the dispensing of influenza vaccine from the Funder. continued...

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 March 2010 (continued)

continued... Inj ............................................................................................. 9.00 90.00 1 10 ✔ Fluvax ✔ Fluarix ✔ Fluarix ✔ Influvac ✔ Vaxigrip

125

TRIFLUOPERAZINE HYDROCHLORIDE Tab 1 mg .................................................................................. 9.83 Tab 2 mg ................................................................................ 14.64 Tab 5 mg ................................................................................ 16.66

100 100 100

✔ Stelazine S29 ✔ Stelazine S29 ✔ Stelazine S29

Effective 1 February 2010

73 PREGNANCY TESTS - HCG URINE – Only on a PSO WSO Cassette – Up to 200 test available on a PSO ......................... 19.00 25 test OP ✔ MDS Quick Card Distributed by MDS Diagnostics, PO Box 24-162, Royal Oak, Auckland. Ph 09 570 5761 INFLUENZA VACCINE – Hospital pharmacy [Xpharm] A) is available between 1 March and 30 June each year for patients who meet the following criteria, as set by the Ministry of Health: a) all people 65 years of age and over; b) people under 65 years of age with: i) the following cardiovascular disease: 1) ischaemic heart disease, 2) congestive heart disease, 3) rheumatic heart disease, 4) congenital heart disease, or 5) cerebo-vascular disease; ii) the following chronic respiratory disease: 1) asthma, if on a regular preventative therapy, or 2) other chronic respiratory disease with impaired lung function; iii) diabetes; iv) chronic renal disease; v) any cancer, excluding basal and squamous skin cancers if not invasive; vi) the following other conditions: a) autoimmune disease, b) immune suppression, c) HIV, d) transplant recipients, e) neuromuscular and CNS diseases, f) haemoglobinopathies, or g) children on long term aspirin. c) people under 65 years of age who are: (i) pregnant; or (ii) morbidly obese d) children under the age of 5 who are enrolled with an Access Primary Health Organisation The following conditions are excluded from funding: a) asthma not requiring regular preventative therapy, b) hypertension and/or dyslipidaemia without evidence of end-organ disease, c) pregnancy in the absence of another risk factor. continued... Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

S29

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 February 2010 (continued)

continued... B) Doctors are the only Contractors entitled to claim payment from the Funder for the supply of influenza vaccine to patients eligible under the above criteria for subsidised immunisation and they may only do so in respect of the influenza vaccine listed in the Pharmaceutical Schedule. C) Individual DHBs may fund patients over and above the above criteria. The claiming process for these additional patients should be determined between the DHB and Contractor. D) Influenza Vaccine does not fall within the definition Community Pharmaceutical as it is not funded directly from the Pharmaceutical Budget. Pharmacists are unable to claim for the dispensing of influenza vaccine from the Funder. Inj ............................................................................................ 9.00 1 ✔ Fluvax ✔ Fluarix 90.00 10 ✔ Fluarix ✔ Vaxigrip 146 EXEMESTANE – Additional subsidy by Special Authority see SA1000 – Retail pharmacy Tab 25 mg ............................................................................. 26.55 30 (175.00) Aromasin ➽ SA1000 Special Authority for Alternate Subsidy Initial Application – from any relevant practitioner. Approvals valid for 5 years for applications meeting the following criteria: All of the following: 1. Patient is a postmenopausal woman; and 2. Patient has hormone receptor positive breast cancer; and 3. Any of the following 3.1 The patient was receiving funded exemestane prior to 1 February 2010; or 3.2 The patient has advanced breast cancer and a very clear history of intolerance to anastrozole or letrozole; or 3.3 The patient has advanced breast cancer and disease has progressed following treatment with anastrozole or letrozole. Renewal from any relevant practitioner. Approvals valid without further renewal unless notified where the treatment remains appropriate and the patient is benefitting from treatment. Note – Repeat dispensings for Aromasin tab 25 mg will be fully subsidised where the initial dispensing was before 1 February 2010.

Effective 1 January 2010

79 SOMATROPIN GROWTH HORMONE BIOSYNTHETIC HUMAN – Special Authority see SA0755 ❋ Inj cartridge 16 iu per vial ..................................................... 249.60 1 ✔ Genotropin 1,248.00 5 ✔ Genotropin ❋ Inj cartridge 36 iu per vial ..................................................... 561.60 1 ✔ Genotropin 2,808.00 5 ✔ Genotropin SOMATROPIN RECOMBINANT HUMAN GROWTH HORMONE – Special Authority see SA0755 ❋ Inj 5 mg ............................................................................... 300.00 1 ✔ Norditropin SimpleXx 5 mg ❋ Inj 10 mg ............................................................................. 600.00 1 ✔ Norditropin SimpleXx 10 mg ❋ Inj 15 mg ............................................................................. 900.00 1 ✔ Norditropin SimpleXx 15 mg

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 January 2010 (continued)

149 CYCLOSPORIN A – Hospital pharmacy [HP3] Cap 25 mg ............................................................................. 59.50 50 Cap 50 mg ........................................................................... 118.54 50 Cap 100 mg ......................................................................... 237.08 50 Oral liq 100 mg per ml .......................................................... 264.17 50 ml OP Note – change in chemical name from cyclosporin A to cyclosporin only. ✔ Neoral ✔ Neoral ✔ Neoral ✔ Neoral

179

ORAL FEED 1.5KCAL/ML – Special Authority see SA0702 – Hospital pharmacy [HP3] Liquid (coffee latte) .................................................................. 1.33 237 ml OP ✔ Ensure Plus

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 March 2010

26 SULPHASALAZINE ( subsidy) ❋ Tab 500 mg ........................................................................... 11.68 ❋ Tab EC 500 mg ...................................................................... 12.89 PARACETAMOL WITH CODEINE ( subsidy) ❋ Tab paracetamol 500 mg with codeine phosphate 8 mg ................................................................... 2.45 (3.24) APOMORPHINE HYDROCHLORIDE ( subsidy) ▲ Inj 10 mg per ml, 2 ml .......................................................... 110.00 LITHIUM CARBONATE ( subsidy) Tab long-acting 400 mg ......................................................... 17.65 LORAZEPAM – Month Restriction ( subsidy) Tab 1 mg ............................................................................... 16.42 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 2.5 mg ............................................................................ 11.17 ‡ Safety cap for extemporaneously compounded oral liquid preparations. 100 100 ✔ Salazopyrin ✔ Salazopyrin EN

112

100 Codalgin 5 100 250 100 ✔ Apomine ✔ Priadel ✔ Ativan ✔ Ativan

121 124 127

Effective 9 February 2010

140 DOCETAXEL – PCT only – Specialist – Special Authority see SA0880 ( subsidy) Inj 1 mg for ECP ..................................................................... 23.81 1 mg ✔ Baxter

Effective 1 February 2010

36 CALCITRIOL ( subsidy) ❋ Cap 0.25 µg ........................................................................... 10.10 ❋ Cap 0.5 µg ............................................................................. 18.73 36 HYDROXOCOBALAMIN ( subsidy) ❋ Inj 1 mg per ml, 1 ml – Up to 6 inj available on a PSO ................ 6.15 FLECAINIDE ACETATE – Retail pharmacy–Specialist ( subsidy) ▲ Tab 50 mg .............................................................................. 45.82 ▲ Tab 100 mg ............................................................................ 80.92 ▲ Cap long-acting 100 mg .......................................................... 45.82 ▲ Cap long-acting 200 mg .......................................................... 80.92 Inj 10 mg per ml, 15 ml ........................................................... 52.45 METOPROLOL SUCCINATE ( subsidy) ❋ Tab long-acting 23.75 mg ......................................................... 2.73 ❋ Tab long-acting 47.5 mg ........................................................... 3.41 ❋ Tab long-acting 95 mg .............................................................. 5.88 ❋ Tab long-acting 190 mg .......................................................... 10.63 100 100 3 ✔ Calcitriol-AFT ✔ Calcitriol-AFT ✔ ABM Hydroxocobalamin ✔ Tambocor ✔ Tambocor ✔ Tambocor CR ✔ Tambocor CR ✔ Tambocor ✔ Betaloc CR ✔ Betaloc CR ✔ Betaloc CR ✔ Betaloc CR

60 60 30 30 5 30 30 30 30

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 February 2010 (continued)

56 SILDENAFIL – Special Authority see SA0968 – Hospital pharmacy [HP1] ( subsidy) Tab 25 mg .............................................................................. 52.00 4 Tab 100 mg ............................................................................ 68.00 4 PERMETHRIN ( subsidy) Crm 5% .................................................................................... 3.65 (4.20) CALCIPOTRIOL ( subsidy) Crm 50 µg per g...................................................................... 20.20 56.32 Oint 50 µg per g ...................................................................... 20.20 56.32 Soln 50 µg per ml ................................................................... 20.22 33.79 GOSERELIN ACETATE – Hospital pharmacy [HP3] ( subsidy) Inj 3.6 mg ............................................................................. 200.00 Inj 10.8 mg ........................................................................... 500.00 SUMATRIPTAN ( subsidy) Tab 50 mg ................................................................................ 1.55 (12.00) (22.00) Tab 100 mg .............................................................................. 1.55 (12.00) (22.00) PIZOTIFEN ( price) ❋ Tab 500 µg ............................................................................ 21.10 30 g OP Lyderm 30 g OP 100 g OP 30 g OP 100 g OP 30 ml OP 60 ml OP 1 1 4 2 ✔ Daivonex ✔ Daivonex ✔ Daivonex ✔ Daivonex ✔ Daivonex ✔ Daivonex ✔ Zoladex ✔ Zoladex ✔ Arrow-Sumatriptan Sumagran Imigran ✔ Arrow-Sumatriptan Sumagran Imigran ✔ Sandomigran ✔ Baxter ✔ Arimidex ✔ Viagra ✔ Viagra

119

120 140 145 146

100

DOCETAXEL – PCT only – Specialist – Special Authority see SA0880 ( subsidy) Inj 1 mg for ECP ..................................................................... 17.55 1 mg ANASTROZOLE ( subsidy) Tab 1 mg ............................................................................... 26.55 30

EXEMESTANE – Additional subsidy by Special Authority see SA1000 – Retail pharmacy ( subsidy) Tab 25 mg .............................................................................. 26.55 30 (175.00) Aromasin

Effective 1 January 2010

30 METFORMIN HYDROCHLORIDE ( subsidy) ❋ Tab immediate-release 500 mg.................................................. 8.09 ❋ Tab immediate-release 850 mg.................................................. 6.67 GLYCEROL ( subsidy) ❋ Suppos 3.6 g – Only on a prescription ....................................... 6.00 500 250 20 ✔ Arrow-Metformin ✔ Arrow-Metformin ✔ PSM

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 January 2010 (continued)

37 CHOLECALCIFEROL ( subsidy) ❋ Tab 1.25 mg (50,000 iu) – Maximum of 12 tab per prescription........................................ 7.76 FOLIC ACID ( subsidy) ❋ Tab 0.8 mg ............................................................................ 19.80 ❋ Tab 5 mg ............................................................................... 10.21 HYDROCORTISONE BUTYRATE ( subsidy) Lipocream 0.1% ........................................................................ 2.30 6.85 Oint 0.1% .................................................................................. 6.85 Milky emul 0.1% ........................................................................ 6.85

12 1,000 500 30 g OP 100 g OP 100 g OP 100 ml OP

✔ Cal-d-Forte ✔ Apo-Folic Acid ✔ Apo-Folic Acid ✔ Locoid Lipocream ✔ Locoid Lipocream ✔ Locoid ✔ Locoid Crelo

HYDROCORTISONE WITH NATAMYCIN AND NEOMYCIN – Only on a prescription ( subsidy) Crm 1% with natamycin 1% and neomycin sulphate 0.5% .......... 2.79 15 g OP ✔ Pimafucort Oint 1% with natamycin 1% and neomycin sulphate 0.5% .......... 2.79 15 g OP ✔ Pimafucort MOMETASONE FUROATE ( subsidy) Crm 0.1% .................................................................................. 2.38 4.55 Oint 0.1% .................................................................................. 2.38 4.55 WOOL FAT WITH MINERAL OIL – Only on a prescription ( price) ❋ Lotn hydrous 3% with mineral oil ............................................... 1.40 (3.50) HYDROCORTISONE BUTYRATE ( subsidy) Scalp lotn 0.1% ......................................................................... 3.65 MEDROXYPROGESTERONE ACETATE ( subsidy) ❋ Inj 150 mg per ml, 1 ml syringe – Up to 5 inj available on a PSO ............................................. 7.15 CYPROTERONE ACETATE WITH ETHINYLOESTRADIOL ( subsidy) ❋ Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs ............... 4.91 (6.30) MEDROXYPROGESTERONE ACETATE ❋ Tab 2.5 mg ( subsidy) ............................................................. 3.09 ❋ Tab 5 mg ( subsidy) .............................................................. 13.06 ❋ Tab 10 mg ( subsidy) .............................................................. 6.85 MEDROXYPROGESTERONE ACETATE ( subsidy) ❋ Tab 100 mg – Retail pharmacy – Specialist ............................. 96.50 ❋ Tab 200 mg – Retail pharmacy – Specialist ............................. 70.50 15 g OP 45 g OP 15 g OP 45 g OP 250 ml OP Hydroderm Lotion 100 ml OP ✔ Locoid ✔ Elocon ✔ Elocon ✔ Elocon ✔ Elocon

66 72

1 84

✔ Depo-Provera

Estelle 35-ED 30 100 30 100 30 ✔ Provera ✔ Provera ✔ Provera ✔ Provera ✔ Provera

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 January 2010 (continued)

79 SOMATROPIN – Special Authority see SA0755 ( subsidy) ❋ Inj cartridge 16 iu per vial ...................................................... 249.60 1,248.00 ❋ Inj cartridge 36 iu per vial ...................................................... 561.60 2,808.00 CABERGOLINE ( subsidy) Tab 0.5 mg – Maximum of 2 tab per prescription; can be waived by Special Authority see SA0175 .................. 16.50 66.00 AMOXYCILLIN CLAVULANATE ( subsidy) Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 2.20 (2.75) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 3.85 (4.75) CLINDAMYCIN ( subsidy) Inj phosphate 150 mg per ml, 4 ml – Retail pharmacy – Specialist............................................................................. 16.00 ISONIAZID – Retail pharmacy – Specialist ( subsidy) No patient co-payment payable ❋ Tab 100 mg ............................................................................ 20.00 ETIDRONATE DISODIUM ( subsidy) ❋ Tab 200 mg ............................................................................ 14.37 (22.80) 23.95 QUININE SULPHATE ( price) ❋ Tab 200 mg ............................................................................ 15.95 (17.20) ‡ Safety cap for extemporaneously compounded oral liquid preparations. CODEINE PHOSPHATE ( subsidy) Tab 15 mg ................................................................................ 5.39 Tab 30 mg ................................................................................ 8.25 Tab 60 mg .............................................................................. 17.76 PETHIDINE HYDROCHLORIDE ( subsidy) a) Only on a controlled drug form b) No patient co-payment payable Tab 50 mg ................................................................................ 3.20 Tab 100 mg .............................................................................. 4.20 1 5 1 5 ✔ Genotropin ✔ Genotropin ✔ Genotropin ✔ Genotropin

2 8

✔ Dostinex ✔ Dostinex

100 ml Augmentin 100 ml Augmentin

✔ Dalacin C

100 60 100 250

✔ PSM

108

Didronel ✔ Etidrate

109

Q 200

111

100 100 100

✔ PSM ✔ PSM ✔ PSM

113

10 10

✔ PSM ✔ PSM

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer's Price – effective 1 January 2010 (continued)

118 PHENOBARBITONE ( subsidy) ❋ Tab 15 mg .............................................................................. 25.00 ❋ Tab 30 mg .............................................................................. 26.00 ALPRAZOLAM – Month Restriction ( subsidy) Tab 250 µg .............................................................................. 3.15 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 500 µg .............................................................................. 4.10 ‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 1 mg .................................................................................. 7.25 ‡ Safety cap for extemporaneously compounded oral liquid preparations. 500 500 50 50 50 ✔ PSM ✔ PSM ✔ Arrow-Alprazolam ✔ Arrow-Alprazolam ✔ Arrow-Alprazolam

127

131

DEXAMPHETAMINE SULPHATE – Special Authority see SA0907 – Retail pharmacy ( subsidy) Only on a controlled drug form Tab 5 mg ................................................................................ 16.50 100 ✔ PSM OXALIPLATIN – PCT only – Specialist – Special Authority see SA0900 ( subsidy) Inj 1 mg for ECP ........................................................................ 1.42 1 mg CYCLOSPORIN – Hospital pharmacy [HP3] ( subsidy) Cap 25 mg .............................................................................. 59.50 Cap 50 mg ............................................................................ 118.54 Cap 100 mg .......................................................................... 237.08 Oral liq 100 mg per ml ........................................................... 264.17 50 50 50 50 ml OP ✔ Baxter ✔ Neoral ✔ Neoral ✔ Neoral ✔ Neoral

136 149

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to General Rules

Effective 1 March 2010

14 “Cost, Brand, Source of Supply” means that the Community Pharmaceutical is eligible for Subsidy on the basis of the Contractor’s annotated purchase price, brand, and source of supply. Alternatively a copy of the invoice for the purchase of the Pharmaceutical may be attached to the prescription, in the place of an annotation, in order to be eligible for Subsidy.

Changes to Sole Subsidised Supply

Effective 1 March 2010

For the list of new Sole Subsidised Supply products effective 1 March 2010 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 8-16.

Changes to Section E Part I

Effective 1 February 2010

Pharmaceuticals and quantities that may be obtained on a Practitioner’s Supply Order 189 PREGNANCY TESTS – HCG URINE ✔ Cassette 200 test Pharmaceuticals that may be obtained on a Wholesale Supply Order 190 PREGNANCY TESTS - HCG URINE ✔ Cassette

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 March 2010

97 PEGYLATED INTERFERON ALPHA-2B WITH RIBAVIRIN – Special Authority see SA0953 – Hospital pharmacy [HP3] See prescribing guideline Inj 50 µg × 4 with ribavirin cap 200 mg × 112 ................. 1,080.40 1 OP ✔ Pegatron Combination Therapy Inj 50 µg × 4 with ribavirin cap 200 mg × 84 ...................... 976.80 1 OP ✔ Pegatron Combination Therapy Inj 80 µg × 4 with ribavirin cap 200 mg × 140 ................. 1,583.60 1 OP ✔ Pegatron Combination Therapy Inj 80 µg × 4 with ribavirin cap 200 mg × 168 ................. 1,687.20 1 OP ✔ Pegatron Combination Therapy Inj 80 µg × 4 with ribavirin cap 200 mg × 84 ................... 1,376.40 1 OP ✔ Pegatron Combination Therapy Inj 100 µg × 4 with ribavirin cap 200 mg × 112 ............... 1,746.40 1 OP ✔ Pegatron Combination Therapy Inj 100 µg × 4 with ribavirin cap 200 mg × 84 ................. 1,642.80 1 OP ✔ Pegatron Combination Therapy Inj 120 µg × 4 with ribavirin cap 200 mg × 140 ............... 2,116.40 1 OP ✔ Pegatron Combination Therapy Inj 120 µg × 4 with ribavirin cap 200 mg × 84 ................. 1,909.20 1 OP ✔ Pegatron Combination Therapy Inj 150 µg × 4 with ribavirin cap 200 mg × 140 ............... 2,516.00 1 OP ✔ Pegatron Combination Therapy Inj 150 µg × 4 with ribavirin cap 200 mg × 168 ............... 2,619.60 1 OP ✔ Pegatron Combination Therapy Inj 150 µg × 4 with ribavirin cap 200 mg × 84 ................. 2,308.80 1 OP ✔ Pegatron Combination Therapy DICLOFENAC SODIUM ❋ Tab EC 25 mg .......................................................................... 3.26 (3.51) ❋ Tab EC 50 mg ........................................................................ 21.30 (25.88) TRIMIPRAMINE MALEATE Cap 25 mg ............................................................................... 6.20 100 Apo-Diclo 500 Apo-Diclo 100 ✔ Tripress

101

115

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 March 2010 (continued)

117 121 127 LAMOTRIGINE ▲ Tab dispersible 200 mg ........................................................ 101.80 BROMOCRIPTINE MESYLATE ❋ Tab 10 mg ........................................................................... 120.86 DIAZEPAM Tab 5 mg – Month Restriction.................................................... 5.00 ‡ Safety cap for extemporaneously compounded oral liquid preparations. PACLITAXEL – PCT only – Specialist Inj 30 mg ................................................................................ 37.95 Note – Paclitaxel Ebewe inj 30 mg, 5 inj pack remains listed. LATANOPROST – Retail pharmacy-Specialist See prescribing guideline ▲ Eye drops 50 µg per ml, 2.5ml ................................................. 9.75 (19.50) PILOCARPINE ❋ Eye drops 1% ........................................................................... 3.24 56 100 250 ✔ Mogine ✔ Alpha-Bromocriptine ✔ Pro-Pam

142

✔ Paclitaxel Ebewe

159

2.5 ml OP Xalatan 15 ml OP ✔ Pilopt

160 181

GLUTEN FREE PASTA – Special Authority see SA0722 – Hospital pharmacy [HP3] Corn and Spinach Rigatini ......................................................... 2.00 250 g OP (2.92) Garlic and Parsley Shells .......................................................... 2.00 250 g OP (2.92) Rice and Corn Garden Herb Pasta ............................................. 2.00 250 g OP (2.92)

Orgran Orgran Orgran

Effective 1 February 2010

30 GLIBENCLAMIDE ❋ Tab 2.5 mg .............................................................................. 3.78 ❋ Tab 5 mg ................................................................................. 3.31 ACEBUTOLOL ❋ Cap 100 mg ............................................................................. 9.50 TRIAMTERENE WITH HYDROCHLOROTHIAZIDE ❋ Tab 50 mg with hydrochlorothiazide 25 mg ............................... 5.00 ISOTRETINOIN – Special Authority see SA0955 – Retail pharmacy Cap 10 mg ............................................................................. 26.93 Cap 20 mg ............................................................................. 38.72 SAQUINAVIR – Special Authority see SA0779 – Hospital pharmacy [HP1] Tab 500 mg ......................................................................... 556.59 DIAZEPAM Tab 2 mg – Month Restriction.................................................... 8.40 ‡ Safety cap for extemporaneously compounded oral liquid preparations. 100 100 100 100 100 100 120 500 ✔ Gliben ✔ Gliben ✔ ACB ✔ Triamizide ✔ Isotane 10 ✔ Isotane 20 ✔ Invirase ✔ Pro-Pam

51 54 58

93 127

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 February 2010 (continued)

150 AZATADINE MALEATE ❋ Tab 1 mg ................................................................................. 6.94 (16.90) BECLOMETHASONE DIPROPIONATE Aerosol inhaler, 50 µg per dose ................................................ 8.54 Aerosol inhaler, 100 µg per dose ............................................ 12.50 Aerosol inhaler, 250 µg per dose ............................................ 22.67 Note – Beclazone CFC-free aerosol inhalers were listed 1 July 2009 PILOCARPINE ❋ Eye drops 6% ........................................................................... 8.56 50 Zadine 200 dose OP ✔ Beclazone 50 200 dose OP ✔ Beclazone 100 200 dose OP ✔ Beclazone 250

151

160

15 ml OP

✔ Pilopt

Effective 1 January 2010

60 CALAMINE a) Only on a prescription b) Not in combination Crm, aqueous, BP ..................................................................... 2.78 (3.02) Lotn, BP .................................................................................. 16.70 (19.44) MEDROXYPROGESTERONE ACETATE ❋ Inj 150 mg per ml, 1 ml – Up to 5 inj available on a PSO ............ 8.05 CO-TRIMOXAZOLE ❋ Oral liq sugar-free trimethoprim 40 mg and sulphamethoxazole 200 mg per 5 ml – Up to 200 ml available on a PSO............... 5.90 DEXTROCHLORPHENIRAMINE MALEATE ❋ Tab long-acting 6 mg ................................................................ 2.70 (7.73) 5.40 (12.56) PILOCARPINE ❋ Eye drops 2% ............................................................................ 4.32

100 g ABM 2,000 ml ABM 1 ✔ Depo-Provera

72 86

500 ml 20

✔ Trisul

151

Polaramine Repetab 40 Polaramine Repetab 15 ml OP ✔ Pilopt

160

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 April 2010

62 MOMETASONE FUROATE Crm 0.1% .................................................................................. 2.38 4.55 Oint 0.1% .................................................................................. 2.38 4.55 CYPROTERONE ACETATE WITH ETHINYLOESTRADIOL ❋ Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs ............... 4.91 (6.30) AMOXYCILLIN CLAVULANATE Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 2.20 (2.75) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml – Up to 200 ml available on a PSO ......................................... 3.85 (4.75) ETIDRONATE DISODIUM ❋ Tab 200 mg ............................................................................ 14.37 (22.80) 23.95 15 g OP 45 g OP 15 g OP 45 g OP 84 Estelle 35-ED ✔ Elocon ✔ Elocon ✔ Elocon ✔ Elocon

100 ml Augmentin 100 ml Augmentin 60 100 Didronel ✔ Etidrate

108

Effective 1 May 2010

30 METFORMIN HYDROCHLORIDE ❋ Tab immediate-release 500 mg.................................................. 8.09 ❋ Tab immediate-release 850 mg.................................................. 6.67 CALCITRIOL ❋ Cap 0.25 µg ........................................................................... 10.10 ❋ Cap 0.5 µg ............................................................................. 18.73 64 PERMETHRIN Crm 5% .................................................................................... 3.65 (4.20) AMOXYCILLIN Grans for oral liq 250 mg per 5 ml – Up to 200 ml available on a PSO ................................................................. 1.27 500 250 100 100 30 g OP Lyderm ✔ Arrow-Metformin ✔ Arrow-Metformin ✔ Calcitriol-AFT ✔ Calcitriol-AFT

100 ml

✔ Ranbaxy Amoxicillin

SUMATRIPTAN Tab 50 mg ................................................................................ 1.55 4 ✔ Arrow-Sumatriptan (12.00) Sumagran (22.00) Imigran Tab 100 mg .............................................................................. 1.55 2 ✔ Arrow-Sumatriptan (12.00) Sumagran (22.00) Imigran Patients pay a manufacturer’s surcharge when S29 Unapproved medicine supplied under Section 29 the Manufacturer’s Price is greater than the Subsidy ‡ safety cap reimbursed Sole Subsidised Supply

119

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 June 2010

52 PINDOLOL ❋ Tab 5 mg ................................................................................. 4.50 ❋ Tab 10 mg ................................................................................ 8.35 ❋ Tab 15 mg ............................................................................. 12.00 FLUCLOXACILLIN SODIUM Cap 250 mg – Up to 30 cap available on a PSO ....................... 18.50 Cap 500 mg ............................................................................ 57.90 PARACETAMOL WITH CODEINE ❋ Tab paracetamol 500 mg with codeine phosphate 8 mg ............. 2.45 (3.24) 100 100 100 250 500 100 Codalgin ✔ Pindol ✔ Pindol ✔ Pindol ✔ Staphlex ✔ Staphlex

112

Effective 1 July 2010

59 SILVER SULPHADIAZINE Crm 1% with chlorhexidine digluconate 0.2% ........................... 15.04 a) Up to 500 g available on a PSO b) Not in combination HYDROCORTISONE BUTYRATE Milky emul 0.1% ........................................................................ 5.00 DITHRANOL Crm 1% ................................................................................... 27.50 SOMATROPIN – Special Authority see SA0755 ❋ Inj 5 mg ................................................................................ 300.00 ❋ Inj 10 mg .............................................................................. 600.00 ❋ Inj 15 mg .............................................................................. 900.00 138 FLUDARABINE PHOSPHATE – PCT only – Specialist Tab 10 mg ........................................................................... 650.25 100 g OP ✔ Silvazine

62 65 80

30 ml OP 50 g OP 1 1 1

✔ Locoid Crelo ✔ Micanol ✔ Norditropin SimpleXx 5 mg ✔ Norditropin SimpleXx 10 mg ✔ Norditropin SimpleXx 15 mg ✔ Fludara

Effective 1 August 2010

34 38 95 BISACODYL – Only on a prescription ❋ Suppos 10 mg .......................................................................... 3.96 FERROUS GLUCONATE WITH ASCORBIC ACID ❋ Tab 170 mg with ascorbic acid 40 mg ..................................... 12.04 12 500 ✔ Fleet ✔ Healtheries Iron with Vitamin C

INTERFERON ALPHA-2A – PCT – Hospital pharmacy [HP3]-Specialist a) See prescribing guideline b) Only one multidose cartridge starter pack to be prescribed and dispensed per patient. Inj 4.5 m iu prefilled syringe .................................................... 46.98 1 ✔ Roferon-A Inj 18 m iu multidose cartridge .............................................. 187.92 1 ✔ Roferon-A Inj 18 m iu multidose cartridge × 2 starter pack ................... 375.84 1 ✔ Roferon-A Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. ❋ Three months or six months, as applicable, dispensed all-at-once

▲

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 August 2010 (continued)

95 INTERFERON ALPHA-2A WITH RIBAVIRIN – Special Authority see SA0784 – Hospital pharmacy [HP3] See prescribing guideline Inj 18 m iu multidose cartridge × 2 with ribavirin tab 200 mg × 168 .............................. 1,375.84 1 OP ✔ Roferon RBV Combination Pack Inj 18 m iu multidose cartridge × 2 with pen and needles with ribavirin tab 200 mg × 168 ............................................ 1,375.84 1 OP ✔ Roferon RBV Combination Pack Starter Kit TRIMIPRAMINE MALEATE Cap 50 mg .............................................................................. 11.20 DEXTROCHLORPHENIRAMINE MALEATE ❋ Tab long-acting 6 mg ................................................................ 5.40 (12.56) 2.70 (7.73) 100 40 Polaramine ColourFree Repetab 20 Polaramine ColourFree Repetab ✔ Tripress

114 151

Effective 1 September 2010

30 COPPER ❋ Tab, diagnostic – Not on a BSO ................................................. 5.02 (31.80) GLUCOSE OXIDASE Urine diagnostic test – Not on a BSO ......................................... 4.11 (7.00) Urine diagnostic test with peroxidase – Not on a BSO ................. 4.11 (6.26) 4.13 (8.65) MULTIVITAMINS – Special Authority see SA0963 – Retail pharmacy Tab ......................................................................................... 19.65 Oral liq .................................................................................... 13.50 AMOXYCILLIN Grans for oral liq 125 mg per 5 ml – Up to 200 ml available on a PSO. ........................................ 1.00 36 OP Clinitest 50 strip OP Diabur 5000 50 strip OP Diastix Clinistix 100 ✔ Ketovite 150 ml OP ✔ Ketovite Liquid

100 ml

✔ Ranbaxy Amoxicillin

107

ALENDRONATE SODIUM WITH CHOLECALCIFEROL – Special Authority see SA0990 – Retail pharmacy Tab 70 mg with cholecalciferol 2,800 iu................................... 35.91 4 ✔ Fosamax Plus

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 September 2010 (continued)

150 161 CYPROHEPTADINE HYDROCHLORIDE ❋ Tab 4 mg .................................................................................. 6.27 PHENYLEPHRINE HYDROCHLORIDE WITH ZINC SULPHATE ❋ Eye drops 0.12% with zinc sulphate 0.25% ................................ 4.51 100 15 ml OP ✔ Periactin ✔ Zincfrin

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 March 2010

ALENDRONATE SODIUM WITH CHOLECALCIFEROL Tab 70 mg with cholecalciferol 2,800 iu .....................................Fosamax Plus 35.91 4 Note – Fosamax Plus tab 70 mg with cholecalciferol 2,800 iu to be delisted 1 May 2010. APOMORPHINE HYDROCHLORIDE ( price) Inj 10 mg per ml, 2 ml ....................Apomine 110.00 5 12

BISACODYL Suppos 10 mg................................Fleet 3.96 Note – Fleet suppos 10 mg to be delisted 1 May 2010. CROTAMITON Crm 10% ........................................Itch-Soothe ETHAMBUTOL HYDROCHLORIDE Tab 400 mg....................................Myambutol LORAZEPAM ( price) Tab 1 mg........................................Ativan Tab 2.5 mg.....................................Ativan 3.79 56.84 16.42 11.17

20 g 56 250 100 30

May-10

Eurax

MEGESTROL ACETATE Tab 160 mg....................................Apo-Megestrol 57.92 Note – Megace tab 160 mg to be delisted 1 May 2010. PREGNANCY TEST – HCG URINE Cassette .........................................Innovacon hCG 22.80 One Step Pregnancy Test Device

May-10

Megace

40 test

May-10

Cards hCG Urine Crystal Clear Clearview Easy hCG Clear Blue Discover Discovery Pregnancy Planning Kit Femfresh First Response Imagine Instant Pregnancy Tests MDS Quick Card MDS Quick Stick Unimark

SULPHASALAZINE Tab 500 mg....................................Salazopyrin Tab EC 500 mg ..............................Salazopyrin EN

11.68 12.89

100 100

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Effective 9 February 2010

DOCETAXEL Inj 20 mg........................................Docetaxel 325.00 1 1% Feb-10 Docetaxel Winthrop Ebewe Taxotere Inj 80 mg........................................Docetaxel 1,300.00 1 1% Feb-10 Docetaxel Winthrop Ebewe Taxotere Note – HSS for Docetaxel Ebewe inj 20 mg and 80 mg has been suspended due to an out-of-stock.

Effective 1 February 2010

BLOOD GLUCOSE DIAGNOSTIC TEST METER Meter .............................................On Call Advanced 9.00 1

BLOOD GLUCOSE DIAGNOSTIC TEST STRIP Blood glucose test strips x 50 and lancets x 5 .................................On Call Advanced 19.10 CALCIPOTRIOL ( price) Crm 50 µg per g .............................Daivonex Oint 50 µg per g .............................Daivonex Crm 50 µg per g .............................Daivonex Oint 50 µg per g .............................Daivonex Soln 50 µg per ml...........................Daivonex Soln 50 µg per ml...........................Daivonex 20.20 20.20 56.32 56.32 20.22 33.79

1 30 g 30 g 100 g 100 g 30 ml 60 ml 1 1 1 1% 1% Apr-10 Apr-10 (B) (B)

CEFEPIME HYDROCHLORIDE ( price and addition of HSS) Inj 1 g, 15 ml ..................................Maxipime 19.55 Inj 2 g, 77 ml ..................................Maxipime 39.10 DACLIZUMAB Inj 25 mg per 5 ml vial ....................Zenapax 635.00 Note – Zenapax inj 25 mg per 5 ml vial to be delisted 1 April 2010. DASATINIB Tab 100 mg....................................Sprycel FLECAINIDE ACETATE Tab 50 mg......................................Tambocor Tab 100 mg....................................Tambocor Cap long-acting 100 mg .................Tambocor CR Cap long-acting 200 mg .................Tambocor CR Inj 10 mg per ml, 15 ml ..................Tambocor GOSERELIN ACETATE ( price) Inj 3.6 mg.......................................Zoladex Inj 10.8 mg.....................................Zoladex HYDROXOCOBALAMIN ( price and addition of HSS) Inj 1 mg per ml, 1 ml ......................ABM 6,214.20 45.82 80.92 45.82 80.92 52.45 200.00 500.00 6.15

30 60 60 30 30 5 1 1 3 1% Apr-10 Neo-B12 Neo-Cytamen

Note – Neo-B12 inj 1 mg per ml, 1 ml to be delisted 1 April 2010.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 February 2010 (continued)

IRON SUCROSE Inj 20 mg per ml, 5 ml ....................Venofer LETROZOLE Tab 2.5 mg.....................................Letara Note – Femara tab 2.5 mg to be delisted 1 April 2010. METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE Cap modified-release 10 mg ...........Ritalin LA 19.50 METOPROLOL SUCCINATE ( price) Tab long-acting 23.75 mg ..............Betaloc CR Tab long-acting 47.5 mg.................Betaloc CR Tab long-acting 95 mg....................Betaloc CR Tab long-acting 190 mg .................Betaloc CR PIZOTIFEN Tab 500 µg ....................................Sandomigran PROMETHAZINE HYDROCHLORIDE Oral liq 5 mg per 5 ml ....................Promethazine Winthrop Elixir 2.73 3.41 5.88 10.63 21.10 3.10 30 30 30 30 30 100 100 ml 1% 1% Apr-10 Apr-10 (B) Phenergan 100.00 26.55 5 30 1% 1% Apr-10 Apr-10 (B) Femara Letrozole Sandoz

RISPERIDONE Oral liq 1 mg per ml ........................Apo-Risperidone 18.35 Tab 0.5 mg.....................................Apo-Risperidone 3.51 Tab 1 mg........................................Apo-Risperidone 6.00 Dr Reddy’s Risperidone Tab 2 mg........................................Apo-Risperidone 11.00 Dr Reddy’s Risperidone Tab 3 mg........................................Apo-Risperidone 15.00 Dr Reddy’s Risperidone Tab 4 mg........................................Apo-Risperidone 20.00 Dr Reddy’s Risperidone

30 ml 60 60 60 60 60

SUMATRIPTAN Tab 50 mg......................................Arrow38.83 100 1% Apr-10 Imigran Sumatriptan Sumagran Tab 100 mg....................................Arrow77.66 100 1% Apr-10 Imigran Sumatriptan Sumagran Note – Arrow-Sumatriptan tab 50 mg 4 tab pack size and 100 mg 2 tab pack size, and Sumagran tab 50 mg and 100 mg, to be delisted 1 April 2010

Effective 1 January 2010

CHOLECALCIFEROL ( price) Tab 50,000 iu .................................Cal-d-Forte CLINDAMYCIN ( price) Inj phosphate 150 mg per ml, 4 ml ...........................................Dalacin C Products with Hospital Supply Status (HSS) are in bold. 7.76 12

16.00

1 (B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

CODEINE PHOSPHATE ( price) Tab 15 mg......................................PSM Tab 30 mg......................................PSM Tab 60 mg......................................PSM CYCLOSPORIN ( price) Cap 25 mg ....................................Neoral Cap 50 mg ....................................Neoral Cap 100 mg ...................................Neoral Oral liq 100 mg per ml ...................Neoral DEXAMPHETAMINE SULPHATE ( price) Tab 5 mg........................................PSM ERYTHROPOIETIN BETA ( price) Inj 2,000 iu prefilled syringe ............NeoRecormon Inj 3,000 iu prefilled syringe ............NeoRecormon Inj 4,000 iu prefilled syringe ............NeoRecormon Inj 5,000 iu prefilled syringe ............NeoRecormon Inj 6,000 iu prefilled syringe ............NeoRecormon Inj 10,000 iu prefilled syringe ..........NeoRecormon 5.39 8.25 17.76 59.50 118.54 237.08 264.17 16.50 120.18 166.87 193.13 243.26 291.92 395.18 100 100 100 50 50 50 50 ml 100 6 6 6 6 6 6 1% 1% Mar-10 Mar-10 Staphlex Staphlex 1% Apr-08 (B) 1% 1% 1% Mar-08 Mar-08 Mar-08 (B) (B) (B)

FLUCLOXACILLIN SODIUM Cap 250 mg ...................................AFT 32.00 250 Cap 500 mg ...................................AFT 110.00 500 Note – Staphlex cap 250 mg and 500 mg to be delisted 1 March 2010. GADOBUTROL Inj 604.72 mg per ml (equivalent to 1 mmol per ml), 7.5 ml prefilled syringe ......................................Gadovist GADODIAMIDE Inj 287 mg per ml, 10 ml ................Omniscan Inj 287 mg per ml, 15 ml ................Omniscan Inj 287 mg per ml, 10 ml pre-filled syringe ......................................Omniscan Inj 287 mg per ml, 15 ml pre-filled syringe ......................................Omniscan Inj 287 mg per ml, 20 ml pre-filled syringe ......................................Omniscan GLYCEROL ( price) Suppos 3.6 g..................................PSM

253.10 180.00 270.00 220.00 330.00 440.00 6.00

5 10 10 10 10 10 20

HEPARINISED SALINE Inj 100 iu per ml, 5 ml ....................Mayne 103.76 50 Note – Mayne’s brand of heparinised saline inj 100 iu per ml, 5 ml to be delisted 1 March 2010.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

HYDROCORTISONE Crm 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort Oint 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort HYDROCORTISONE BUTYRATE (new listing) Scalp lotn 0.1% ..............................Locoid HYDROCORTISONE BUTYRATE ( price) Lipocream 0.1% ............................Locoid Lipocream Lipocream 0.1% ............................Locoid Lipocream Milky emulsion 0.1% .....................Locoid Crelo Oint 0.1% (brand name change)......Locoid Ointment IODIXANOL (new listing) Inj 320 mg per ml (iodine equivalent), 150 ml .........Visipaque Inj 320 mg per ml (iodine equivalent), 200 ml .........Visipaque IODIXANOL ( price and addition of HSS) Inj 270 mg per ml (iodine equivalent), 50 ml ...........Visipaque Inj 270 mg per ml (iodine equivalent), 100 ml .........Visipaque Inj 320 mg per ml (iodine equivalent), 50 ml ...........Visipaque Inj 320 mg per ml (iodine equivalent), 100 ml .........Visipaque IODIXANOL (addition of HSS) Inj 320 mg per ml (iodine equivalent), 200 ml .........Visipaque IOHEXOL ( price and addition of HSS) Inj 240 mg per ml (iodine equivalent), 50 ml ......................Omnipaque

2.79 2.79 3.65 2.30 6.85 6.85 6.85

15 g 15 g 100 ml 30 g 100 g 100 ml 100 g

670.50 894.00

10 10

5% 5%

Apr-10 Apr-10

(B) (B)

223.50 447.00 223.50 447.00

10 10 10 10

5% 5% 5% 5%

Apr-10 Apr-10 Apr-10 Apr-10

(B) (B) (B) (B)

565.56

Apr-10

(B)

77.80

Apr-10

Iomeron Isovue 50 ml & 100 ml Opitray Ultravist Iomeron Isovue Optiray 20 ml & 30 ml Ultravist

Inj 300 mg per ml (iodine equivalent), 20 ml ......................Omnipaque

24.00

Apr-10

continued... Products with Hospital Supply Status (HSS) are in bold. (B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

continued... Inj 300 mg per ml (iodine equivalent), 50 ml ......................Omnipaque 77.80 10 5% Apr-10 Iomeron Isovue Optiray Ultraject 50 ml & 75 ml Ultravist Iomeron Isovue Optiray 100 ml, 150 ml & 200 ml Ultraject 125 ml Ultravist (B) Iomeron Isovue Optiray 20 ml & 30 ml Ultraject 30 ml Ultravist 30 ml Iomeron Isovue Optiray Ultraject Ultravist Iomeron Optiray Ultraject Iomeron Isovue Optiray Ultraject 100 ml & 125 ml Ultravist Iomeron Isovue Optiray Ultravist (B)

Inj 300 mg per ml (iodine equivalent), 100 ml ....................Omnipaque

155.60

Apr-10

Inj 300 mg per ml (iodine equivalent), 500 ml ....................Omnipaque Inj 350 mg per ml (iodine equivalent), 20 ml ......................Omnipaque

468.00 24.00

6 6

5% 5%

Apr-10 Apr-10

Inj 350 mg per ml (iodine equivalent), 50 ml ......................Omnipaque

77.80

Apr-10

Inj 350 mg per ml (iodine equivalent), 75 ml ......................Omnipaque Inj 350 mg per ml (iodine equivalent), 100 ml ....................Omnipaque

116.70

Apr-10

155.60

Apr-10

Inj 350 mg per ml (iodine equivalent), 200 ml ....................Omnipaque

186.70

Apr-10

Inj 350 mg per ml (iodine equivalent), 500 ml ....................Omnipaque ISONIAZID ( price) Tab 100 mg....................................PSM

780.00 20.00

10 100

Apr-10

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

MEDROXYPROGESTERONE ACETATE Inj 150 mg per ml, 1 ml, syringe (new listing)...................Depo-Provera Tab 2.5 mg ( price).......................Provera Tab 5 mg ( price)..........................Provera Tab 10 mg ( price)........................Provera Tab 100 mg ( price)......................Provera Tab 200 mg ( price)......................Provera

7.15 3.09 13.06 6.85 96.50 70.50

1 30 100 30 100 30

1% 1% 1% 1% 1%

Sept-07 Sept-07 Sept-07 Sept-07 Sept-07

Cycrin Cycrin Cycrin (B) (B)

MEGLUMINE DIATRIZOATE WITH SODIUM AMIDOTRIZOATE Oral soln 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml ...........................Gastrografin 21.00 MEGLUMINE GADOPENTETATE Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml vial ......Magnevist MESALAZINE Tab EC 500 mg ..............................Asamax PETHIDINE HYDROCHLORIDE ( price) Tab 50 mg......................................PSM Tab 100 mg....................................PSM PHENOBARBITONE Tab 15 mg......................................PSM Tab 30 mg......................................PSM PINDOLOL Tab 5 mg........................................Apo-Pindolol Tab 10 mg......................................Apo-Pindolol Tab 15 mg......................................Apo-Pindolol QUININE SULPHATE ( price) Tab 200 mg....................................Q 200

184.00 49.50 3.20 4.20 25.00 26.00 5.40 9.19 13.80 17.20

10 100 10 10 500 500 100 100 100 250 1% 1% 1% Mar-10 Mar-10 Mar-10 Pindol Pindol Pindol

RECOMBINANT FACTOR VIII Inj 250 IU .......................................Xyntha 225.00 1 Inj 500 IU .......................................Xyntha 450.00 1 Inj 1,000 IU ....................................Xyntha 900.00 1 Inj 2,000 IU ....................................Xyntha 1,800.00 1 Note – Refacto brand of recombinant factor VIII inj 250 iu, 500 iu, 1,000 iu and 2,000 iu to be delisted 1 April 2010. SILVER SULPHADIAZINE Crm 1% ..........................................Flamazine SOLIFENACIN SUCCINATE Tab 5 mg........................................Vesicare Tab 10 mg......................................Vesicare 12.30 56.50 56.50 50 g 30 30

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 January 2010 (continued)

TROPISETRON (addition of HSS) Cap 5 mg .......................................Navoban 77.41 5 1% Mar-10 (B)

Effective 1 December 2009

AMOXYCILLIN Grans for oral liq 125 mg per 5 ml ..Ospamox Grans for oral liq 250 mg per 5 ml .Ospamox ATROPINE SULPHATE ( price and discontinuing HSS) Eye drops 1% ................................Atropt 1.55 1.10 100 ml 100 ml

Feb-10

Amoxil Ranbaxy Amoxicillin (B)

17.36

15 ml

Dec-08

ATROPINE SULPHATE Inj 1200 µg, 1 ml............................AstraZeneca 32.00 50 Note – AstraZeneca inj 1200 µg, 1 ml to be delisted 1 February 2010. BLEOMYCIN SULPHATE Inj 15,000 iu ...................................Blenoxane 680.00 Note – Blenoxane inj 15,000 iu to be delisted 1 February 2010. CALCITRIOL Cap 0.25 µg ..................................Airflow Cap 0.5 µg .....................................Airflow 3.03 5.62 10

30 30

1% 1%

Feb-10 Feb-10

Calcitriol-AFT Rocaltrol Caltriol-AFT Rocaltrol

Note – Calcitriol-AFT cap 0.25 µg and 0.5 µg to be delisted 1 February 2010. CEPHALEXIN MONOHYDRATE Grans for oral liq 125 mg per 5 ml ..Cefalexin Sandoz Grans for oral liq 250 mg per 5 ml ..Cefalexin Sandoz 8.50 11.50 100 ml 100 ml 1% 1% Feb-10 Feb-10 (B) (B)

DOCETAXEL Inj 20 mg........................................Docetaxel 325.00 1 Ebewe Inj 80 mg........................................Docetaxel 1,300.00 1 Ebewe Note – Taxotere inj 20 mg and 80 mg to be delisted 1 February 2010. ETHAMBUTOL HYDROCHLORIDE Tab 100 mg....................................Myambutol FUROSEMIDE Tab 500 mg....................................Urex Forte 57.81 50.00 56 50

1% 1%

Feb-10 Feb-10

Docetaxel Winthrop Taxotere Docetaxel Winthrop Taxotere

HYDROXYETHYL STARCH 200/0.5 PENTASTARCH (amended description) Inj Inf 10% per 500 ml bag ..............StarQuin 10% 216.00 16

Sept-08

Pentaspan

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II - effective 1 December 2009 (continued)

LETROZOLE ( price) Tab 2.5 mg.....................................Femara 146.46 30

MEGLUMINE DIATRIZOATE WITH SODIUM AMIDOTRIZOATE ( price) Oral soln 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml ...........................Gastrografin 210.00 10 MEGLUMINE GADOPENTETATE Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 10 ml prefilled Syringe ( price) ........................Magnevist 92.00 5 Inj 469 mg per ml (equivalent to 0.5 mmol per ml), 20 ml ............Magnevist 33.85 1 Note – Magnevist inj 469 mg per ml, 20 ml to be delisted 1 February 2010. PERMETHRIN Lotn 5% .........................................A-Scabies Note – Lyderm crm 5% to be delisted 1 February 2010. 3.65 30 ml 1% Feb-10 Lyderm

POLYETHYLENE GLYCOL WITH SODIUM SULPHATE ( price) Powder, sachets .............................Klean-Prep 16.46 QUETIAPINE ( price) Tab 25 mg......................................Quetapel Tab 100 mg....................................Quetapel Tab 200 mg....................................Quetapel Tab 300 mg ...................................Quetapel 16.78 32.59 56.70 95.40

4 90 90 90 90

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands A ABM Hydroxocobalamin ..................................... 25 ACB ................................................................... 32 Acebutolol.......................................................... 32 Actigall .............................................................. 20 Alendronate sodium with cholecalciferol ....... 36, 38 Alpha-Bromocriptine .......................................... 32 Alprazolam ......................................................... 29 Amoxycillin ............................................ 34, 36, 45 Amoxycillin clavulanate ................................ 28, 34 Anastrozole ........................................................ 26 Apo-Diclo........................................................... 31 Apo-Folic Acid ................................................... 27 Apo-Megestrol ............................................. 18, 38 Apo-Pindolol ................................................ 19, 44 Apo-Risperidone .................................... 18, 19, 40 Apomine ...................................................... 25, 38 Apomorphine hydrochloride ......................... 25, 38 Arimidex ............................................................ 26 Aromasin ..................................................... 23, 26 Arrow-Alprazolam .............................................. 29 Arrow-Metformin.......................................... 26, 34 Arrow-Sumatriptan ........................... 18, 26, 34, 40 Asamax ....................................................... 19, 44 A-Scabies .......................................................... 46 Ativan .......................................................... 25, 38 Atropine sulphate ............................................... 45 Atropt ................................................................ 45 Augmentin ................................................... 28, 34 Azatadine maleate .............................................. 33 B Beclazone 50 ..................................................... 33 Beclazone 100 ................................................... 33 Beclazone 250 ................................................... 33 Beclomethasone dipropionate............................. 33 Betaloc CR ................................................... 25, 40 Bisacodyl ..................................................... 35, 38 Blenoxane .......................................................... 45 Bleomycin sulphate ............................................ 45 Blood glucose diagnostic test meter ............. 18, 39 Blood glucose diagnostic test strip ............... 18, 39 Bromocriptine mesylate...................................... 32 C Cabergoline........................................................ 28 Calcitriol ...................................................... 25, 34 Calcitriol-AFT ............................................... 25, 34 Cal-d-Forte................................................... 27, 40 Calamine............................................................ 33 Calcipotriol................................................... 26, 39 Cardizem CD ...................................................... 20 Cefalexin Sandoz ................................................ 45 Cefepime hydrochloride...................................... 39 Cephalexin monohydrate .................................... 45 Chlorhexidine gluconate ..................................... 17 Cholecalciferol ............................................. 27, 40 Clindamycin ................................................. 28, 40 Clinistix .............................................................. 36 Clinitest.............................................................. 36 Co-trimoxazole ................................................... 33 Codalgin ...................................................... 25, 35 Codeine phosphate ...................................... 28, 41 Copper............................................................... 36 Crotamiton ................................................... 17, 38 Cyclosporin.................................................. 29, 41 Cyclosporin A .................................................... 24 Cyproheptadine hydrochloride ............................ 37 Cyproterone acetate with ethinyloestradiol .... 27, 34 D Daclizumab ........................................................ 39 Daivonex ...................................................... 26, 39 Dalacin C ..................................................... 28, 40 Dasatinib...................................................... 19, 39 Depo-Provera ......................................... 27, 33, 44 Dexamphetamine sulphate............................ 29, 41 Dextrochlorpheniramine maleate ................... 33, 36 Diabur 5000 ....................................................... 36 Diastix ............................................................... 36 Diazepam........................................................... 32 Diclofenac sodium ............................................. 31 Didronel ....................................................... 28, 34 Diltiazem hydrochloride ...................................... 20 Dithranol ............................................................ 35 Docetaxel ......................................... 25, 26, 39, 45 Docetaxel Ebewe .......................................... 39, 45 Dostinex ............................................................ 28 Dr Reddy’s Risperidone.......................... 18, 19, 40 E Elocon ......................................................... 27, 34 Ensure Plus........................................................ 24 Erythropoietin beta ............................................. 41 Estelle 35-ED ............................................... 27, 34 Ethambutol hydrochloride ............................. 38, 45 Etidrate ........................................................ 28, 34 Etidronate disodium ..................................... 28, 34 Exemestane ................................................. 23, 26 F Femara .............................................................. 46 Ferrous gluconate with ascorbic acid .................. 35 Flamazine..................................................... 19, 44 Flecainide acetate......................................... 25, 39 Fleet............................................................. 35, 38 Flixonase Hayfever & Allergy .............................. 19 Fluarix .......................................................... 22, 23 Flucloxacillin sodium .............................. 19, 35, 41

Index

Pharmaceuticals and brands Fludara............................................................... 35 Fludarabine phosphate ....................................... 35 Fluticasone propionate ....................................... 19 Fluvax .......................................................... 22, 23 Folic acid ........................................................... 27 Fosamax Plus .............................................. 36, 38 Furosemide ........................................................ 45 G Gadobutrol ......................................................... 41 Gadodiamide...................................................... 41 Gadovist ............................................................ 41 Gastrografin ................................................. 44, 46 Genotropin ................................................... 23, 28 Gliben ................................................................ 32 Glibenclamide .................................................... 32 Glucose oxidase................................................. 36 Gluten free pasta ................................................ 32 Glycerol ....................................................... 26, 41 Goserelin acetate ......................................... 26, 39 Growth hormone biosynthetic human ................. 23 H Habitrol ........................................................ 20, 21 Healtheries Iron with Vitamin C ........................... 35 Heparinised saline .............................................. 41 Hydrocortisone .................................................. 42 Hydrocortisone butyrate ......................... 27, 35, 42 Hydrocortisone with natamycin and neomycin .... 27 Hydroderm Lotion .............................................. 27 Hydroxocobalamin ....................................... 25, 39 Hydroxyethyl starch 200/0.5 .............................. 45 I Influvac ........................................................ 18, 22 Influenza vaccine.................................... 17, 21, 22 Innovacon hCG One Step Pregnancy Test Device ............................................... 17, 38 Interferon alpha-2a ............................................. 35 Interferon alpha-2a with ribavirin......................... 36 Invirase .............................................................. 32 Imigran ........................................................ 26, 34 Iodixanol ............................................................ 42 Iohexol ............................................................... 42 Iron sucrose....................................................... 40 Isoniazid ...................................................... 28, 43 Isotane 10.......................................................... 32 Isotane 20.......................................................... 32 Isotretinoin ......................................................... 32 Itch-Soothe .................................................. 17, 38 K Ketovite ............................................................. 36 Ketovite Liquid ................................................... 36 Klean-Prep ......................................................... 46 L Lamotrigine........................................................ 32 Latanoprost........................................................ 32 Letara .......................................................... 19, 40 Letrozole ................................................ 19, 40, 46 Lithium carbonate .............................................. 25 Locoid ......................................................... 27, 42 Locoid Crelo .......................................... 27, 35, 42 Locoid Lipocream ........................................ 27, 42 Locoid Ointment................................................. 42 Lorazepam ................................................... 25, 38 Lyderm ........................................................ 26, 34 M Magnevist .................................................... 44, 46 Maxipime ........................................................... 39 MDS Quick Card ................................................ 22 Medroxyprogesterone acetate................. 27, 33, 44 Megestrol acetate......................................... 18, 38 Meglumine diatrizoate with sodium amidotrizoate ............................................ 44, 46 Meglumine gadopentetate............................. 44, 46 Mesalazine ................................................... 19, 44 Methylphenidate hydrochloride extended-release ....................................... 19, 40 Metformin hydrochloride .............................. 26, 34 Metoprolol succinate .................................... 25, 40 Micanol.............................................................. 35 Mogine .............................................................. 32 Mometasone furoate .................................... 27, 34 Multivitamins ..................................................... 36 Myambutol................................................... 38, 45 N Navoban ............................................................ 45 Neoral .................................................... 24, 29, 41 NeoRecormon .................................................... 41 Nicotine ....................................................... 20, 21 Nicotinell ............................................................ 20 Norditropin SimpleXx 5 mg ........................... 23, 35 Norditropin SimpleXx 10 mg ......................... 23, 35 Norditropin SimpleXx 15 mg ......................... 23, 35 O Omnipaque .................................................. 42, 43 Omniscan .......................................................... 41 On Call Advanced ......................................... 18, 39 Oral feed 1.5kcal/ml ........................................... 24 Orgran ............................................................... 32 Ospamox ........................................................... 45 Oxaliplatin .......................................................... 29 P Paclitaxel ........................................................... 32 Paclitaxel Ebewe ................................................ 32

Index

Pharmaceuticals and brands Paracetamol with codeine ...................... 19, 25, 35 ParaCode ........................................................... 19 Pegatron Combination Therapy ........................... 31 Pegylated interferon alpha-2b with ribavirin ......... 31 Pentastarch........................................................ 45 Periactin ............................................................ 37 Permethrin ............................................. 26, 34, 46 Pethidine hydrochloride ................................ 28, 44 Phenobarbitone ............................................ 29, 44 Phenylephrine hydrochloride with zinc sulphate .. 37 Pilocarpine ................................................... 32, 33 Pilopt ........................................................... 32, 33 Pimafucort ................................................... 27, 42 Pindol ................................................................ 35 Pindolol ................................................. 19, 35, 44 Pizotifen ....................................................... 26, 40 Polaramine Colour-Free Repetab ........................ 36 Polaramine Repetab ........................................... 33 Polyethylene glycol with sodium sulphate ........... 46 Pregnancy tests - hCGg urine ........... 17, 22, 30, 38 Priadel ............................................................... 25 Promethazine Winthrop Elixir ........................ 19, 40 Pro-Pam ............................................................ 32 Promethazine hydrochloride ......................... 19, 40 Provera ........................................................ 27, 44 Q Q 200 .......................................................... 28, 44 Quetapel ............................................................ 46 Quetiapine.......................................................... 46 Quinine sulphate .......................................... 28, 44 R Ranbaxy Amoxicillin ..................................... 34, 36 Recombinant factor viii....................................... 44 Recombinant human growth hormone ................ 23 Risperidone.................................................. 18, 40 Ritalin LA ..................................................... 19, 40 Roferon-A .......................................................... 35 Roferon RBV Combination Pack ......................... 36 Roferon RBV Combination Pack Starter Kit ......... 36 S Salazopyrin .................................................. 25, 38 Salazopyrin EN ............................................. 25, 38 Sandomigran ............................................... 26, 40 Saquinavir .......................................................... 32 Sildenafil ............................................................ 26 Silvazine ............................................................ 35 Silver sulphadiazine ................................ 19, 35, 44 Solifenacin succinate ................................... 19, 44 Somatropin ............................................ 23, 28, 35 Sprycel ........................................................ 19, 39 Staphlex ............................................................. 35 StarQuin 10% ..................................................... 45 Stelazine ............................................................ 22 Sulphasalazine ............................................. 25, 38 Sumagran .................................................... 26, 34 Sumatriptan ..................................... 18, 26, 34, 40 T Tambocor .................................................... 25, 39 Tambocor CR .............................................. 25, 39 Triamizide .......................................................... 32 Triamterene with hydrochlorothiazide.................. 32 Trifluoperazine hydrochloride .............................. 22 Trimipramine maleate ................................... 31, 36 Tripress ....................................................... 31, 36 Trisul ................................................................. 33 Tropisetron ........................................................ 45 U Urex Forte .......................................................... 45 Ursodeoxycholic acid ......................................... 20 V Vaxigrip ....................................................... 22, 23 Venofer .............................................................. 40 Vesicare....................................................... 19, 44 Viagra ................................................................ 26 Visipaque ........................................................... 42 Vitabdeck ........................................................... 17 Vitamins ............................................................ 17 W Wool fat with mineral oil ..................................... 27 X Xalatan............................................................... 32 Xyntha ............................................................... 44 Z Zadine................................................................ 33 Zenapax ............................................................. 39 Zincfrin .............................................................. 37 Zoladex ........................................................ 26, 39

Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-9376 (Print) ISSN 1179-3686 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

Metadata

Title

Schedule Update - effective 1 March 2010

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March 2010 Cumulative for January, February and March 2010 Section H cumulative for December 2009, January, February and March 2010 Contents Summary of PHARMAC decisions effective 1 March 2010 …..…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.